A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Humanigen Inc () said Monday that its lead drug candidate lenzilumab was selected for use in the National Institute of Health’s upcoming coronavirus trial. The biopharmaceutical company’s lenzilumab, an anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody drug candidate, will be evaluated in the National Institute of Allergy and Infectious Diseases’ (NIAID) Big Effect Trial (BET) in patients hospitalized with COVID-19. In a statement, California-based Humanigen said that the trial will help to advance NIAID's strategic plan for COVID-19 research, which includes conducting studies to advance high-priority therapeutic candidates and identify agents with novel mechanisms of action for therapy -- a “strategic priority” for the institute, according to Humanigen.
Technology Inc () granted options to purchase 100,000 shares to certain employees under its stock option plan, it reported Monday. The shares are priced at C$1.12 per share under a five-year period from the issue date. The company helps businesses to integrate cryptocurrency into their payment model.
Talon Metals Corp () (OCTMKTS:TLOFF) announced Monday that it has commissioned the next phase of exploration at the Tamarack nickel-copper-cobalt project in Minnesota as well as hydromet testing of recently produced nickel concentrates. The company has been conducting borehole and surface electromagnetic surveys at the Tamarack Project, covering large areas of the approximate 18-kilometer Tamarack Intrusive Complex. The goal is to refine previously identified conductors that could constitute high-grade nickel and copper mineralization outside of the company's resource area. Drilling is expected to commence during the second week of August 2020. Talon also announced the preliminary results of its flowsheet development to produce nickel sulphates for the electric vehicle (EV) market. The company said a nickel flotation concentrate was processed successfully to extract over 99% of the contained nickel and cobalt and about 88% of the copper that was not captured in the separate copper concentrate.
Ltd () (OTCQB:AAGFF) revealed that it has inked a binding letter of intent with SSR Mining Inc to buy the Berenguela silver-copper project in Puno, Peru by acquiring all SSR Mining’s shares in the Peruvian holding company Sociedad Minera Berenguela SA for nearly US$13 million in staged cash payments, an investment in Aftermath shares and net smelter return royalties. The Canadian junior explorer focused on silver said the Berenguela silver–copper project is an epithermal polymetallic carbonate-replacement deposit with a total tenement package of 6,594 hectares. A historic estimate shows the Peruvian project contains 98 million ounces of silver measured and indicated, and 28 million ounces of silver inferred. Aftermath Silver CEO Ralph Rushton said when the Berenguela acquisition is complete, the company will have "one of the largest portfolios of silver development assets"
Virtual Investor Conferences, the proprietary virtual event series from OTC Markets Group Inc (), released the agenda for its upcoming two-day Metals and Mining Virtual lnvestor Conference starting on July 30. The free event is designed to connect individual and institutional investors, analysts and advisors with metals and mining executives who will discuss their property positions, development schedules, market opportunity, and investment highlights. The two-day virtual event is scheduled to begin with a keynote address from well known Harvard-trained geologist Byron King at 9:30 am on July 30. "We are pleased to host the Canadian Metals and Mining Virtual Investor conference and highlight the achievements of a diverse roster of resource companies," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group.
Karora Resources Inc (), formerly known as RNC Minerals Corp (TSE:RNX), has closed on a deal to sell its 28% interest in the Dumont nickel project in Quebec to two private funds advised by Waterton Global Resource Management Inc. Karora said Monday it has received $10.7 million in cash, comprised of $7.4 million from Waterton for its interest and a $3.3 million refund of Karora's share of the cash held within the Dumont Joint Venture. As previously outlined, Karora will have the right to receive a portion of future proceeds of any future Dumont sale or other monetization event up to a maximum of an additional $40.2 million.
District Metals Corp () (OTCMKTS:MKVNF) released historic drill data from its Tomtebo project in Sweden that revealed high grade polymetallic drill intercepts at the formerly producing mine. The drill data from the Steffenburgs zone on the property show “substantial” intervals of mineralization around 200 metres to 317 metres below surface, the company said in a statement Monday, adding that the mineralization remains open along strike and at depth. Highlights of the drill data, which was carried out over a 50-year period by a Swedish-owned company, include intercepts of up to 1,458 grams per ton (g/t) silver equivalent (AgEq) or 11.4% zinc equivalent (ZnEq) at 1.6 metres. Another hole drilled from the 200 metre level intersected 16.2 metres at 535.7 g/t AgEq or 13.8% ZnEq, while yet another intersected 9.81 metres at 441.3 g/t AgEq or 11.4% ZnEq.
(), which is developing its non-invasive glucose monitor and digital healthcare subscription service proBeat, said Monday it has entered into a letter of intent (LOI) to acquire diabetes firm Healthimation LLC. Healthimation is commercialising an application-based diabetes prevention program that has been developed over a period of over 12 years and is supported with clinical data that has been widely published in scientific journal articles, according to a statement. The program is delivered using Hollywood level animation deploying creative user engagement strategies, with a unique program structure aimed at maintaining muscle mass and enhancing metabolism to improve overall health and prevent the regaining of weight. Nemaura believes these features could form a strong complement to the proBEAT subscription service Nemaura plans to offer in the US.
(NYSEAMERICAN:GORO), a gold and silver producer with operations in Mexico and the US, announced a July dividend on Monday of one-third of C$0.01 per common share. The dividend is payable on August 24 to shareholders on record as of August 11. The company has returned $114 million to its shareholders in consecutive monthly dividends since July 2010 and offers its shareholders the option to convert their cash dividends into physical gold and silver.
BioLargo Inc () has released highlights from its annual meeting of stockholders, which was held virtually on July 23. During the meeting, its subsidiary Clyra Medical announced the release of its Clyraguard Disinfecting Personal Protective Spray, which eliminates the coronavirus from PPE, the company said. Also, BioLargo Engineering's water treatment technology is being prepared for its first commercial trials within the next 3-4 months. The company said it has converted $1.1 million of debt into equity in 2020, with another $1.9 million expected to be converted in the third quarter. "One thing that is unique and special about BioLargo is the capacity for our talented business units to collaborate and leverage synergy for development and commercialization of our products and services,” CEO Dennis Calvert said in a statement. “We are well positioned for explosive top line revenue growth and are anxious to prove it with results."
Biome Grow Inc () () announced Monday it is selling its Highland Grow Inc subsidiary to MYM Nutraceuticals Inc (CSE:MYM) (OTCMKTS:MYMMF) in a C$12.9 million deal. The deal consideration includes around 175.3 million common and special shares of MYM Nutraceuticals, making Biome Grow the cannabis producer’s largest shareholder with a 19% stake in the company. In a statement, Biome Grow’s CEO Khurram Malik told investors that the sale – and resulting ownership of MYM shares – was a “great opportunity” to benefit Biome shareholders.
ImagineAR Inc () (OTC:IPNFF), an augmented reality company, told investors Monday that a contract with a major North American sports and entertainment company (NASEC) is imminent. The deal has not yet officially closed, but the unnamed company has put ImagineAR on notice that an agreement is on the horizon. ImagineAR, for its part, said it believes all major hurdles on the path to a contract have been cleared. The size of the NASEC in question and the unspecified amount of time until the contract is officially closed prompted ImagineAR to inform investors ahead of time, the company said. ImagineAR also said that it is in various stages of discussions with other major brands and retailers about providing AR solutions to deliver consumer engagement and activation during the coronavirus pandemic.
() () said on Monday that its proposed acquisition of Altum Pharmaceuticals Inc and plans to develop AP-003 to treat coronavirus (COVID-19) are advancing. The company said a special meeting of Altum shareholders, more than 72% of whom have signed a lock-up agreement, is scheduled for July 29 to approve the merger. The results of the vote will be announced shortly thereafter. BetterLife also said Altum is making progress with the US Food and Drug Administration (FDA) following its May request for a pre-Investigational New Drug (IND) meeting on AP-003 (Interferon Alpha-2b for inhalation).
Loop Insights Inc () (OCTMKTS:VRZPF), a provider of contactless solutions and artificial intelligence to drive marketing, announced on Thursday that it has enlisted Maple Leaf Strategies to streamline the company’s engagement with both the Canadian federal government and provincial government of Ontario. Maple Leaf Strategies is Canada’s leading public affairs, government relations and public opinion research firm, with a track record of success at the provincial level across the country, as well as at the federal level, across multiple administrations over the years. Loop said it is “confident” that Maple Leaf Strategies will “accelerate the visibility of Loop’s contact tracing solution” on the east coast of Canada.
Inc () (OTCMKTS:BRGGF) said Monday that its subsidiary ORYX Gaming has agreed to supply a portfolio of popular games and casino content to gambling and entertainment solutions powerhouse PLC (). The group noted that is “integrating” content aggregator ORYX’s remote gaming server (RGS) platform content, featuring proprietary ORYX games and premium titles from partner studios like Gamomat, Kalamba Games, Givme Games and Golden Hero Games.
ORYX’s has access to nearly 8,000 games from its suppliers. Gamomat Games offers over 100 titles exclusive to ORYX with features including unique side-game jackpots that have proven to be extremely popular with players.
BevCanna Enterprises Inc () (), a dominant player in the infused cannabis beverages industry, said Monday that the company’s board has appointed beverage industry pioneer Douglas Mason to its independent advisory board. As an experienced C-suite level executive and board member in the hemp processing and natural foods sector, Mason spent nearly 20 years leading Clearly Food & Beverage Company Ltd (NASDAQ:CCBC). In his role as founder CEO he led the company to annual sales of more than $155 million. The Vancouver-based firm said Mason will share his beverage expertise with BevCanna as it continues on its rapid growth trajectory, and will work with the company on identifying and securing domestic and international M&A opportunities.
. () () (FSE:4WE), a federally-licensed producer and distributor of medical-grade cannabis, has announced the resignation of Dr Hugh Scully from its Board of Directors, effective immediately. “Dr Scully was recently reappointed to the Board of Directors, but a personal matter has arisen which has led him to submit his resignation. Dr Scully has been on the Board of Starseed since its inception in 2013 and was an important contributor to its success,” said George Scorsis, executive chairman of WeedMD.
() (FSE:S5GM) said it has arranged a private placement financing of up to 6,500,000 units at a price of $0.06 per unit for total gross proceeds of up to $390,000. Each unit consists of one common share and a whole warrant, with each warrant exercisable into one additional common share at $0.07 for a period of two years after the closing date. The company intends to use the net proceeds of the Financing for corporate working capital purposes. The private placement is subject to approval of the TSX Venture Exchange.
() said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced on May 20, 2020, and June 1, 2020, which sees the issue of 33,432,110 shares at a price of 12.5 cents each with 39 placees.
Loop Insights Inc () said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced on July 20, 2020, which will see the issue of 5,686,904 shares at a purchase price of 10.5 cents per share, together with 5,686,904 warrants at an exercise price of 25 cents for a two-year period with four placees.
()(OTCPINK:PACXF)(FSE:2NKN) announced that it has granted incentive stock options under its stock option plan to directors, officers and consultants for the purchase of up to 1,750,000 common shares at a price of $1.33 per share for a period of three years, subject to the acceptance of the TSX Venture Exchange.
Versus Systems, Inc. () () (FSE: MVA) announced that it has granted an aggregate of 4,153,500 incentive stock options to certain directors, officers, employees and consultants under the company's Stock Option Plan, subject to regulatory approval. The options will be exercisable at $0.25 for a period of five years and subject to vesting provisions.
. () said it has granted stock options to its directors, officers and consultants in the aggregate amount of 1.5 million common shares, exercisable at 5 cents for five years. The option agreements are granted according to the company's stock option plan.
(), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, has said that Nader Pourhassan, its president and chief executive officer, Scott Kelly, its chairman, chief medical officer and head of Business Development, and Jacob Lalezari, its senior science advisor, will host an investment community conference call on Thursday, July 30, 2020, at 1.00pm PT/4.00pm ET to provide a comprehensive update on the company’s two trials for coronavirus (COVID-19) patients with mild-to-moderate and severe-to-critical indications. It said the management will dedicate approximately 45 minutes to address questions from analysts and investors, as a follow-on to the Q&A session from the recent special meeting of stockholders. The dial-In numbers for the call are: US 877-407-8291; International 201-689-8345. A live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 30 days. The webcast can also be accessed via the following link: https://78449.themediaframe.com/dataconf/productusers/cydy/mediaframe/39976/indexl.html. A replay of the conference call will be available until August 30, 2020, via: US 877-660-6853; International 201-612-7415; conference identification number 13707751.
AIM ImmunoTech (NYSEAMERICAN:AIM) has announced that it will be presenting at the SNN Network Virtual Investor Conference on Monday, August 3, 2020, at 1.30pm EST. It said Thomas K. Equels, chief executive officer of AIM Immunotech, will be hosting the presentation and answering questions from investors. To access the live presentation, please use the following information: Webcast - https://www.webcaster4.com/Webcast/Page/2059/35938. For investors that are unable to attend the live presentation, the webcast replay will be available directly on the conference event platform under the tab "Schedule," at: https://conference.snn.network/page-3371.
Vehicles Corp.(), a designer and manufacturer of electric vehicles, has announced that it will be presenting at the SNN Network Virtual Investor Conference on Wednesday, August 5, 2020 at 2.00pm Eastern time (11.00 Pacific time). The group said its chief financial officer, Bal Bhullar will host the presentation. Following the presentation the company will be conducting one-on-one meetings with investors and analysts. Bhullar will also be participating on a panel titled, "Importance of Women Representation on Small, Micro, Nano-Cap Executive Teams and Boardrooms," hosted by Luisa Ingargiola. The panel will be archived on the conference website following its broadcast. All company presentation “webcasts” will be available for replay directly on the conference event platform via this link under the “Schedule” tab: https://conference.snn.network/page-3371
(), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, will be presenting at the Alpha Bronze Virtual Town Hall on Wednesday, July 29, 2020, at 12.00pm EDT. Dr Heman Chao, chief executive officer of Helix will give an 10 to 15 minutes overview of the company, its Lung Cancer and Pancreatic Cancer Clinical programs and upcoming milestones. Dr Chao will respond to Investors questions thereafter for another 10 to 15 minutes The presentation will be webcast live. You can access register to the Virtual Town Hall with the following link: https://zoom.us/webinar/register/WN_0tdX0OQrTuS_gJCk53zVTQ
() () has announced that its president, Jack Stoch will present live at VirtualInvestorConferences.com on Thursday, July 30, 2020, at 1.30pm ET via the following link: https://www.tinyurl.com/073020MiningVIC. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
